GARY A LYONS Insider Trading $VICL Brickell Biotech, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY A LYONS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY A LYONS. GARY A LYONS is in Brickell Biotech, Inc. ($VICL) and Director in VICAL INC ($VICL) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Novus Therapeutics, Inc. ($TKAI) and Director in Retrophin, Inc. ($RTRX).
GARY A LYONS in Brickell Biotech, Inc.
Trading Symbol: VICLIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GARY A LYONS: Director
Holdings: 24,729 shares
Current Value: $52,673
Latest Transaction: Sep 17 2020
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GARY A LYONS in Brickell Biotech, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Grant | A | 0.81 | 11,934 | 9,667 | 24,729 | 12.8 K to 24.7 K (+93.27 %) |
Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 0 | |
Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 8,631 | 8,113 | 12,795 | 21.4 K to 12.8 K (-40.28 %) |
Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 346 | 325 | 21,426 | 21.8 K to 21.4 K (-1.59 %) |
Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 21,772 | 21.1 K to 21.8 K (+3.28 %) |
Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.92 | 346 | 318 | 21,080 | 21.4 K to 21.1 K (-1.61 %) |
Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 21,426 | 20.7 K to 21.4 K (+3.34 %) |
Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 691 | 0 | 1,384 | |
Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.00 | 346 | 346 | 20,734 | 21.1 K to 20.7 K (-1.64 %) |
Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 691 | 0 | 21,080 | 20.4 K to 21.1 K (+3.39 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | A | 1.12 | 4,333 | 4,853 | 4,333 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 691 | 0 | 691 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 3,491 | 0 | 3,491 | |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Grant | A | 0.00 | 17,261 | 0 | 20,389 | 3.1 K to 20.4 K (+551.82 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.16 | 346 | 401 | 3,128 | 3.5 K to 3.1 K (-9.96 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 3,474 | 2.8 K to 3.5 K (+24.87 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.20 | 346 | 415 | 2,782 | 3.1 K to 2.8 K (-11.06 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 3,128 | 2.4 K to 3.1 K (+28.41 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.19 | 346 | 412 | 2,436 | 2.8 K to 2.4 K (-12.44 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 691 | 0 | 2,782 | 2.1 K to 2.8 K (+33.05 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 2.93 | 346 | 1,014 | 2,091 | 2.4 K to 2.1 K (-14.20 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 2,437 | 1.7 K to 2.4 K (+39.66 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.16 | 1,746 | 2,025 | 1,745 | 3.5 K to 1.7 K (-50.01 %) |
Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 3,491 | 0 | 3,491 | 0 to 3.5 K |
Feb 19 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Option Exercise | A | 1.16 | 8,333 | 9,666 | 8,333 | ||
Feb 19 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Option Exercise | A | 1.16 | 2,167 | 2,514 | 2,167 | ||
May 24 2018 | VICL | VICAL INC | LYONS GARY A | Director | Option Exercise | A | 1.67 | 6,500 | 10,855 | 6,500 | |
May 30 2017 | VICL | VICAL INC | LYONS GARY A | Director | Option Exercise | A | 2.36 | 6,500 | 15,340 | 6,500 | |
Dec 07 2016 | VICL | VICAL INC | LYONS GARY A | Director | Sell | S | 2.30 | 7,078 | 16,248 | 7,828 | 14.9 K to 7.8 K (-47.48 %) |
Jun 06 2016 | VICL | VICAL INC | LYONS GARY A | Director | Buy | P | 4.39 | 7,078 | 31,089 | 14,906 | 7.8 K to 14.9 K (+90.42 %) |
May 24 2016 | VICL | VICAL INC | LYONS GARY A | Director | Option Exercise | A | 0.36 | 65,000 | 23,465 | 65,000 | |
May 26 2015 | VICL | VICAL INC | LYONS GARY A | Director | Option Exercise | A | 0.89 | 50,000 | 44,500 | 50,000 | |
May 26 2015 | VICL | VICAL INC | LYONS GARY A | Director | Grant | A | 0.01 | 7,500 | 75 | 78,281 | 70.8 K to 78.3 K (+10.60 %) |
Page: 1